PRF and Amniotic Membrane in Wound Healing

Comparison of the Effectiveness of Amniotic Membrane and Platelet Rich Fibrin (PRF) Treatments on Wound Healing in Split Thickness Skin Graft Donor Sites

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240116060705N1

Enrollment

Registered

2024-09-04

Start date

2024-09-22

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Healing in Split Thickness Skin Graft Donor Sites. Open wound of unspecified body region

Interventions

Intervention 1: Intervention group: Group 1: Patients assigned to the PRF treatment group will receive PRF application on the donor site of a split-thickness graft. PRF is a concentrate of platelets a

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age Between 18 and 60 Years No History of Disease Normal BMI

Exclusion criteria

Exclusion criteria: Age Smaller than 18 or Greater than 60 Having a History of Disease BMI Greater than 25 or Smaller than 18

Design outcomes

Primary

Measure	Time frame
Wound dimensions at certain timeframe. Timepoint: Measuring the dimensions of the wound at the beginning of the study (when the wound was created) and 4, 7, 14, and 21 days later. Method of measurement: Ruler or tape measure.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Ghahramani

Shiraz University of Medical Sciences

z.ghrmn@gmail.com+98 71 3612 2265

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026